A new ratio for better predicting future death/myocardial infarction than standard lipid measurements in women >50 years undergoing coronary angiography: The apolipoprotein A1 remnant ratio (Apo A1/ [VLDL 3+IDL])

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  May, Heidi T ^a   Nelson, John R ^b   Kulkarni, Krishnaji R ^c   Anderson, Jeffrey L ^a,d   Horne, Benjamin D ^a,d   Bair, Tami L ^a   Muhlestein, Joseph B ^a,d  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Atherotech   (United States)

^d UNIVERSITY OF UTAH   (United States)

Author keywords

Apolipoprotein A1; Lipid; Lipoprotein; Outcomes; Remnant lipoproteins; Risk; Women

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL ESTER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERMEDIATE DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREDICTOR VARIABLE; PREMENOPAUSE; STENOSIS;

AGED; APOLIPOPROTEIN A-I; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, VLDL; MALE; MENOPAUSE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTMENOPAUSE; PROGNOSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 84876669596     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-55     Document Type: Article

References (52)

1. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation 2011 123 18 e209 [published correction appears in Circulation. 2011;123:e240] 10.1161/CIR.0b013e3182009701 21160056
2. Manson JE, Prevention of myocardial infarction New York: Oxford University Press 1996
3. Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR, Ann Epidemiol 1992 2 161 176 10.1016/1047-2797(92)90051-Q 1342259
4. Cardiovascular disease in women. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M, Circulation 1993 88 1999 2009 10.1161/01.CIR.88.4. 1999 8403349
5. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, Stampfer MJ, Ma J, Circulation 2004 110 2824 2830 10.1161/01.CIR.0000146339. 57154.9B 15492318 (Pubitemid 39473604)
6. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR, Am J Med 1977 62 707 714 10.1016/0002-9343(77)90874-9 193398 (Pubitemid 8110784)
7. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): A prospective study. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E, Lancet 2001 358 2026 2033 10.1016/S0140-6736(01)07098-2 11755609 (Pubitemid 34084825)
8. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PWF, Ordovas JM, Schaefer EJ, Atherosclerosis 2001 154 229 236 10.1016/S0021-9150(00)00484-6 11137104 (Pubitemid 32010711)
9. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, on behalf of the INTERHEART Study Investigators, Lancet 2004 364 937 951 10.1016/S0140-6736(04)17018-9 15364185 (Pubitemid 39208455)
10. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Simons L, Dwyer T, Somons J, Bernstein L, Mock P, Poonia N, Balasubramaniam S, Baron D, Branson J, Morgan P, Roy P, Atherosclerosis 1987 65 181 189 10.1016/0021-9150(87)90020-7 3496893 (Pubitemid 17065441)
11. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death. Takeichi S, Yukawa N, Nakajima Y, Osawa M, Saito T, Seto Y, Nakano T, Saniabadi AR, Adachi M, Wang T, Nakajima K, Atherosclerosis 1999 142 309 315 10.1016/S0021-9150(98)00246-9 10030382 (Pubitemid 29059489)
12. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apo B-lipoprotein-depleted plasma (FERHDL). Dobiasova M, Frohlich J, Clin Biochem 2001 34 583 588 10.1016/S0009-9120(01)00263-6 11738396 (Pubitemid 34014853)
13. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: A Report From the Women's Ischemia Syndrome Evaluation (WISE). Bitner V, Johnson D, Zineh I, Rogers WJ, Vido D, Marroquin OC, Bairey-Merz CN, Sopko G, Am Heart J 2009 157 548 555 10.1016/j.ahj.2008.11.014 19249427
14. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Frohlich J, Dobiasova M, Clin Chem 2003 49 1873 1880 10.1373/clinchem.2003.022558 14578319 (Pubitemid 37340322)
15. Association of triglyceride-to-HDL cholesterol ratio with heart rate recovery. Shishehbor MH, Hoogwerf BJ, Lauer MS, Diabetes Care 2004 27 936 941 10.2337/diacare.27.4.936 15047652 (Pubitemid 38420218)
16. The role of lipids and lipoproteins in atherosclerosis. Gofman J, Lindgren F, Elliott H, Mantz W, Hewitt J, Strisower B, Herring V, Lyon TP, Science 1950 111 166 171 10.1126/science.111.2877.166 15403115
17. High plasma level of remnant-like particle cholesterol in the metabolic syndrome. Satoh A, Adachi H, Tsuruta M, Hirai Y, Hiratsuka A, Enomot M, Furuki K, Hino A, Takeuchi T, Imaizumi T, Diabetes Care 2005 28 2514 2518 10.2337/diacare.28.10.2514 16186289 (Pubitemid 41384303)
18. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients. Watanabe N, Taniguchi T, Taketoh H, Kitagawa Y, Namura H, Yoneda N, Kurimoto Y, Yamada S, Ishikawa Y, Diabetes Care 1999 22 152 156 10.2337/diacare.22.1.152 10333918 (Pubitemid 29028313)
19. Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women. Lamon-Fava S, Herrington DM, Reboussin DM, Sherman M, Horvath KV, Cupples A, White C, Demissie S, Schaefer EJ, Asztalos BF, Arterioscler Thromb Vasc Biol 2008 28 575 579 10.1161/ATVBAHA.107.157123 18174456
20. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H, Circulation 1999 99 2858 2860 10.1161/01.CIR.99.22.2858 10359727 (Pubitemid 29258971)
21. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Phillips NR, Waters D, Havel RJ, Circulation 1993 88 2762 2770 10.1161/01.CIR.88.6.2762 8252689 (Pubitemid 23360203)
22. Apolipoprotein A1 predicts future death and myocardial infarction in patients undergoing coronary angiography even when they have normal baseline HDL levels. May HT, Kulkarni K, Horne BD, Anderson JL, Bair TL, Mower CP, Carlquist JF, Muhlestein JB, J Am Coll Cardiol 2010 55 10A 55 (1128)
23. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. National Cholesterol Education Program Coordinating Committee, Circulation 2002 160 3143 3421
24. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. Ridker PM, Hennekens CH, Buring JE, Rifai N, N Engl J Med 2000 342 836 843 10.1056/NEJM200003233421202 10733371 (Pubitemid 30165206)
25. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women? LaRosa JC, Wom Health Iss 1992 2 111 113
26. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R, for the Prospective Studies Collaboration, Lancet 2007 370 1829 1839 18061058 (Pubitemid 350180032)
27. Friend turns foe: transformation of ant-inflammatory HDL to proinflammatory HDL during acute-phase response. HB G, Rao VS, Kakkar VV, Cholesterol 2011 274629 Epub 2010 Nov 25
28. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-1: significance for cardiovascular risk. The IDEAL and EPIC-Norfolk studies. van der Steeg WA, Holme I, Boekholdt SM, Larsen ML, Lindahl C, Stroes ES, Tikkanen MJ, Wareham NJ, Faergeman O, Olsson AG, Pedersen TR, Khaw KT, Kastelein JJ, J Am Coll Cardiol 2008 51 634 642 10.1016/j.jacc.2007.09.060 18261682 (Pubitemid 351186873)
29. Predictive value of remnant-like particles cholesterol/high-density lipoprotein cholesterol ratio as a new indicator of coronary artery disease. Masuoka H, Ishikura K, Kamei S, Obe T, Seko T, Okuda K, Koyabu S, Tsuneoka K, Tamai T, Sugawa M, Nakano T, Am Heart J 1998 136 226 230 10.1053/hj.1998.v136. 89586 9704682 (Pubitemid 28368842)
30. Impact of high remnant-like lipoproteins on the function of peripheral arterial endothelium in patients with hyperlipidemia and normolipidemia: estimation using Doppler flow analysis. Funada J, Sekiya M, Otani T, Watanabe K, Akutsu H, J Cardiol 2001 37 267 276 11392896 (Pubitemid 32521944)
31. Lipoprotein remnants and endothelial dysfunction in the postprandial phase. Maggi FM, Raselli S, Grigore L, Redaelli L, Fantappié S, Catapano A, J Clin Endocrinol Metab 2004 89 2946 2950 10.1210/jc.2003-031977 15181082 (Pubitemid 38766390)
32. Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism. Doi H, Kugiyama K, Oka H, Sugiyama S, Ogata N, Koide SI, Nakamura SI, Yasue H, Circulation 2000 102 670 676 10.1161/01.CIR.102.6.670 10931808 (Pubitemid 30640668)
33. Plasma lipoproteins enhance tissue factor-independent factor VII activation. Kjalke M, Silveira A, Hamsten A, Hedner U, Ezban M, Arterioslcer Thromb Vasc Biol 2000 20 1835 1841 10.1161/01.ATV.20.7.1835 (Pubitemid 30470603)
34. Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes. Moyer MP, Tracy RP, Tracy PB, van't Veer C, Sparks CE, Mann KG, Arterioscler Thromb Vasc Biol 1998 18 458 465 10.1161/01.ATV.18.3.458 9514415 (Pubitemid 28125641)
35. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. Fukushima H, Sugiyama S, Honda O, Koide S, Nakamura S, Sakamoto T, Yoshimura M, Ogawa H, Fujioka D, Kugiyama K, J Am Coll Cardiol 2004 43 2219 2224 10.1016/j.jacc.2003. 09.074 15193683 (Pubitemid 38757588)
36. High lipid levels and coronary disease in women in Göteborg-outcome and secular trends: a prospective 19 year follow-up in the BEDA study. Johansson S, Wilhelmsen L, Lappas G, Rosengren A, Eur Heart J 2003 24 704 716 12713765 (Pubitemid 36458983)
37. Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women. Stensvold I, Tverdal A, Urdal P, Graff-Iversen S, BMJ 1993 307 1318 1322 10.1136/bmj.307.6915.1318 8257886 (Pubitemid 23337748)
38. Triglycerides + high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the Cardiovascular Study in the Elderly. Mazza A, Tikhonoff V, Schiavon L, Casiglia E, Intern Med J 2005 35 604 610 10.1111/j.1445-5994.2005.00940.x 16207260 (Pubitemid 41564407)
39. The Dubbo study of the health of elderly: correlates of coronary heart disease at study entry. Simons LA, Friedlander Y, McCallum J, Simons J, Powell I, Heller R, Berry G, J Am Geriatr Soc 1991 39 584 590 2037749
40. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V, Circulation 2007 115 450 458 10.1161/CIRCULATIONAHA.106.637793 17190864 (Pubitemid 46184196)
41. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM, JAMA 2007 298 309 316 10.1001/jama.298.3.309 17635891 (Pubitemid 47080485)
42. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ, de Graaf J, Furberg CD, Circ Cardiovasc Qual Outcomes 2011 4 337 345 10.1161/CIRCOUTCOMES. 110.959247 21487090
43. Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? Sniderman A, McQueen M, Contois J, Williams K, Furberg CD, J Clin Lipidol 2010 4 152 155 10.1016/j.jacl.2010.03.005 21122647
44. Atherosclerosis and arterial influx of lipoproteins. Nordestgaard BG, Nielsen LB, Curr Opin Lipidol 1994 5 252 257 10.1097/00041433-199408000-00002 7981955 (Pubitemid 24249558)
45. Role of heparin sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. Ji ZS, Brecht WJ, Miranda RD, Hussain MM, Innerarity TL, Mahley RW, J Biol Chem 1993 268 10160 10167 7683668 (Pubitemid 23150196)
46. Nutritional status of menopausal women. Karnataka J, Agric Sci 2008 21 152 154
47. The effect of hormone replacement therapy on metabolism of lipoprotein remnants in postmenopausal women. Sanada M, Nakagawa H, Kodama I, Sakasita T, Ohama K, Maturitas 2000 34 75 82 10.1016/S0378-5122(99)00087-0 10687885 (Pubitemid 30015990)
48. Implementation of a computerized cardiovascular information system in a private hospital setting. Taylor GS, Muhlestein JB, Wagner GS, Bair TL, Li P, Anderson JL, Am Heart J 1998 136 792 803 10.1016/S0002-8703(98)70123-1 9812073 (Pubitemid 28506878)
49. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. Anonymous, N Engl J Med 1984 310 750 758 6608052
50. Quantification of cholesterol in all lipoprotein classes by the VAP-II method. Kulkarni KR, Garber DW, Marcovina SM, Segrest JP, J Lipid Res 1994 35 59 168
51. A novel approach to measure apolipoprotein A/apolipoprotein A1 ratio using the Vertical Auto Profile method. Kulkarni KR, Tiwari H, Jones SR, Diab Vasc Dis Res 2007 4 266
52. Definition of the metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Grundy SM, Brewer B, Cleeman JI, Smith SC, Lenfant C, for the Conference Participants, Circulation 2004 109 433 438 10.1161/01.CIR. 0000111245.75752.C6 14744958 (Pubitemid 38133916)